Cite
HARVARD Citation
Joode, K. et al. (n.d.). 31P The IOpener study: Tyrosine kinase activity profiling to predict response to immune checkpoint inhibitors in patients with advanced stage non-small cell lung cancer. Immuno-oncology technology. p. . [Online].